Abiopharma

(99% Positive) BGC GROUP, INC. (BGC) Reports Q2 2026 Financial Results

(30% Negative) CORE MOLDING TECHNOLOGIES INC (CMT) Reports Q2 2026 Financial Results

(99% Neutral) PATRICK INDUSTRIES INC (PATK) Announces Business Combination

IHS Towers Completes Sale of Its 51.0% Stake in I-Systems to TIM S.A.

(30% Negative) TURNING POINT BRANDS, INC. (TPB) Reports Q2 2026 Financial Results

(35% Negative) CRA INTERNATIONAL, INC. (CRAI) Reports Q2 2026 Financial Results

(35% Negative) INSIGHT ENTERPRISES INC (NSIT) Reports Q2 2026 Financial Results

(30% Negative) PRIME MEDICINE, INC. (PRME) Reports Q2 2026 Financial Results

(30% Negative) FILANA THERAPEUTICS, INC. (FLNA) Reports Q2 2026 Financial Results

(90% Positive) ATARA BIOTHERAPEUTICS, INC. (ATRA) Provides Update on leader for a pre-specified manner

New Form SCHEDULE 13G - Equillium, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001716774-26-000015 <b>Size:</b> 8 KB

ONE Nuclear Energy Announces Two Independent Director Nominees for Public Company Board

(30% Negative) LIFETIME BRANDS, INC (LCUT) Reports Q2 2026 Financial Results

(62% Positive) RACKSPACE TECHNOLOGY, INC. (RXT) Reports Q2 2026 Financial Results

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001839882-26-023272 <b>Size:</b> 719 KB